HUM · News · 20260807N

Generic Drug Price-Fixing Litigation

HUMANA INC · 2026-08-07 · Importance 34 · Surprise 42

Humana’s antitrust claims alleging that generic-drug manufacturers conspired to inflate prices will proceed to a bellwether trial in the U.S. District Court for the Eastern District of Pennsylvania. The trial is intended to test a representative case and may help determine the direction of similar claims. Teva Pharmaceuticals, one of the defendants, is seeking to prevent jurors from being told that it is Israeli, citing potential prejudice related to public sentiment surrounding the Gaza war.

Key facts

• Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana securities who bought shares before June 27, 2022 and still hold them. source